文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

从20种肿瘤类型中鉴定铜死亡相关的预后基因表达特征

Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.

作者信息

Ooko Ednah, Ali Nadeen T, Efferth Thomas

机构信息

Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Department of Biological Sciences, School of Natural and Applied Sciences, Masinde Muliro University of Science and Technology, Kakamega 190-50100, Kenya.

出版信息

Biology (Basel). 2024 Oct 3;13(10):793. doi: 10.3390/biology13100793.


DOI:10.3390/biology13100793
PMID:39452102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505359/
Abstract

We investigated the mRNA expression of 124 cuproptosis-associated genes in 7489 biopsies from 20 different tumor types of The Cancer Genome Atlas (TCGA). The KM plotter algorithm has been used to calculate Kaplan-Meier statistics and false discovery rate (FDR) corrections. Interaction networks have been generated using Ingenuity Pathway Analysis (IPA). High mRNA expression of 63 out of 124 genes significantly correlated with shorter survival times of cancer patients across all 20 tumor types. IPA analyses revealed that their gene products were interconnected in canonical pathways (e.g., cancer, cell death, cell cycle, cell signaling). Four tumor entities showed a higher accumulation of genes than the other cancer types, i.e., renal clear cell carcinoma ( = 21), renal papillary carcinoma ( = 13), kidney hepatocellular carcinoma ( = 13), and lung adenocarcinoma ( = 9). These gene clusters may serve as prognostic signatures for patient survival. These signatures were also of prognostic value for tumors with high mutational rates and neoantigen loads. Cuproptosis is of prognostic significance for the survival of cancer patients. The identification of specific gene signatures deserves further exploration for their clinical utility in routine diagnostics.

摘要

我们研究了来自癌症基因组图谱(TCGA)中20种不同肿瘤类型的7489份活检样本中124个铜死亡相关基因的mRNA表达情况。使用KM plotter算法计算了Kaplan-Meier统计量和错误发现率(FDR)校正值。利用 Ingenuity 通路分析(IPA)生成了相互作用网络。在所有20种肿瘤类型中,124个基因中有63个基因的高mRNA表达与癌症患者较短的生存时间显著相关。IPA分析显示,它们的基因产物在经典通路(如癌症、细胞死亡、细胞周期、细胞信号传导)中相互关联。四种肿瘤实体显示出比其他癌症类型更多的基因积累,即肾透明细胞癌(= 21)、肾乳头状癌(= 13)、肾肝细胞癌(= 13)和肺腺癌(= 9)。这些基因簇可作为患者生存的预后标志物。这些标志物对具有高突变率和新抗原负荷的肿瘤也具有预后价值。铜死亡对癌症患者的生存具有预后意义。鉴定特定的基因标志物在常规诊断中的临床应用值得进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/93d49f1fb1aa/biology-13-00793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/481e256ef2ca/biology-13-00793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/97cd4c938850/biology-13-00793-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/93d49f1fb1aa/biology-13-00793-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/481e256ef2ca/biology-13-00793-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/97cd4c938850/biology-13-00793-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9356/11505359/487369354154/biology-13-00793-g004.jpg

相似文献

[1]
Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.

Biology (Basel). 2024-10-3

[2]
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.

Biochem Genet. 2024-6

[3]
Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.

Int J Mol Sci. 2023-1-11

[4]
Multi-omics pan-cancer study of cuproptosis core gene and its role in kidney renal clear cell carcinoma.

Front Immunol. 2022

[5]
Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.

Ann Transl Med. 2022-11

[6]
Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.

Biomolecules. 2022-12-16

[7]
Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.

Mediators Inflamm. 2023

[8]
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.

Transl Cancer Res. 2024-3-31

[9]
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.

Front Genet. 2023-2-10

[10]
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.

Front Immunol. 2022

引用本文的文献

[1]
p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation.

Front Oncol. 2025-6-24

本文引用的文献

[1]
Cuproptosis in lung cancer: therapeutic options and prognostic models.

Apoptosis. 2024-10

[2]
Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors.

Innovation (Camb). 2024-4-9

[3]
A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.

BMC Cancer. 2024-4-23

[4]
Targeting cuproplasia and cuproptosis in cancer.

Nat Rev Clin Oncol. 2024-5

[5]
Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.

Curr Med Chem. 2024-2-14

[6]
Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine.

Brief Bioinform. 2023-11-22

[7]
Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority.

Front Immunol. 2023

[8]
Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer.

Br J Pharmacol. 2024-2

[9]
Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.

Front Immunol. 2023

[10]
The therapeutic potential of targeting regulated non-apoptotic cell death.

Nat Rev Drug Discov. 2023-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索